Source of funding and outcome of clinical trials

Journal of General Internal Medicine
R A Davidson

Abstract

Because of recent concerns about conflicts of interest and published research, the author analyzed 107 controlled clinical trials. Studies were classified as favoring either a new therapy or a traditional therapy, and as being supported by a pharmaceutical manufacturer or as being generally supported. Seventy-one per cent of the trials favored new therapies; 43% of these were funded by pharmaceutical firms. Of the 31 trials favoring traditional therapy, only four (13%) were supported by a pharmaceutical firm. There was a statistically significant association between the source of funding and the outcome of the study (p = 0.002). Few trials supported by pharmaceutical manufacturers favored traditional therapy; some reasons for this finding may include selection of drugs likely to be proven efficacious, Type II errors (false-negative studies), and fear of discontinuation of funding should such studies be submitted. Important clinical information may be lost if negative studies are not published.

References

Jul 26, 1979·The New England Journal of Medicine·R H Fletcher, S W Fletcher
Nov 1, 1978·Annals of Internal Medicine·C M Kunin
Dec 20, 1984·The New England Journal of Medicine·UNKNOWN Copenhagen Esophageal Varices Sclerotherapy Project
Dec 1, 1984·Annals of Internal Medicine·J J HollowayP S Lietman
Nov 1, 1984·The American Journal of Medicine·R CadeD Hood-Lewis
Jul 1, 1983·Reviews of Infectious Diseases·D M Musher
May 3, 1984·The New England Journal of Medicine·A S Relman
Jan 1, 1984·Reviews of Infectious Diseases·C M Kunin
Aug 9, 1984·The New England Journal of Medicine
Aug 9, 1984·The New England Journal of Medicine
Oct 1, 1982·JAMA : the Journal of the American Medical Association·P G Rochmis
Jan 1, 1985·Journal of Chronic Diseases·Samuel Shapiro

❮ Previous
Next ❯

Citations

Apr 15, 2000·Journal of Clinical Apheresis·E C Vamvakas
May 1, 1990·Journal of General Internal Medicine·N LurieW P McKinney
Aug 8, 2001·Current Oncology Reports·M Barbieri, M F Drummond
Feb 24, 2001·Science and Engineering Ethics·D B Resnik
Oct 2, 2002·Science and Engineering Ethics·James Robert Brown
Oct 2, 2002·Science and Engineering Ethics·Laurence J Hirsch
Apr 13, 1991·Lancet·P J EasterbrookD R Matthews
Nov 9, 2002·Lancet·Joe Collier, Ike Iheanacho
Jan 1, 1996·International Journal of Technology Assessment in Health Care·L A Bero, D Rennie
May 18, 2000·The New England Journal of Medicine·T Bodenheimer
Jun 1, 2000·The New England Journal of Medicine·R MoynihanS B Soumerai
Dec 9, 2008·The American Journal of Bioethics : AJOB·Jeffrey Spike
Dec 10, 2009·The American Journal of Bioethics : AJOB·Jeremy Howick
Mar 25, 2010·The Annals of Occupational Hygiene·Celeste MonfortonKathleen Ruff
Jun 11, 2002·Topics in Magnetic Resonance Imaging : TMRI·Mildred K Cho
Jan 14, 2004·Seminars in Dialysis·William M Bennett
Jan 30, 2004·Journal of General Internal Medicine·Lee S Friedman, Elihu D Richter
Aug 27, 1999·Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine·C R Reed, C A Camargo
Jul 17, 1998·BMJ : British Medical Journal·D P Kernick
May 31, 2003·BMJ : British Medical Journal·Joel LexchinOtavio Clark
Apr 26, 2003·American Journal of Respiratory and Critical Care Medicine·Martin J Tobin
Sep 3, 2005·Critical Care : the Official Journal of the Critical Care Forum·Gordon Duval
Jan 13, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Susannah L RoseSteven Joffe
Oct 19, 2007·PLoS Medicine·Jan P VandenbrouckeUNKNOWN STROBE Initiative
Sep 22, 2011·Canadian Journal of Surgery. Journal Canadien De Chirurgie·Chris S BaileyCharles G Fisher
Feb 16, 2005·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Richelle J Cooper, David L Schriger
Mar 1, 2005·Mens Sana Monographs·Ajai Singh, Shakuntala Singh
Mar 1, 2005·Mens Sana Monographs·Ajai Singh, Shakuntala Singh
Oct 17, 2007·Annals of Internal Medicine·Jan P VandenbrouckeUNKNOWN STROBE initiative
Feb 7, 2002·Lancet·Paul S ThomasDeborah H Yates
Dec 14, 2001·Lancet·J S MontanerM T Schechter
Sep 8, 2010·Expert Review of Neurotherapeutics·Vinod Kumar Gupta
Apr 9, 2009·Accountability in Research·Patricia M TereskerzJonathan D Moreno
Nov 8, 2015·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Colin SonViktor Bartanusz
Dec 25, 2002·The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics·Mark Barnes, Patrik S Florencio
Mar 3, 2009·Gaceta sanitaria·Jan P VandenbrouckeUNKNOWN Iniciativa STROBE
Jun 15, 2011·The Journal of Hand Surgery·Kevin C ChungGordon Van Ummersen
Jan 5, 2011·Journal of Clinical Epidemiology·Leon Bax, Karel G Moons
Nov 26, 2010·The Journal of Evidence-based Dental Practice·Argy PolychronopoulouTheodore Eliades

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Therapeutic Innovation & Regulatory Science
Kinya Okada, Shintaro Sengoku
Revista Portuguesa De Cardiologia : Orgão Oficial Da Sociedade Portuguesa De Cardiologia = Portuguese Journal of Cardiology : an Official Journal of the Portuguese Society of Cardiology
L L Reis
Türk psikiyatri dergisi = Turkish journal of psychiatry
Halis UlaşKöksal Alptekin
© 2021 Meta ULC. All rights reserved